Загрузка...
α(1)-Antitrypsin deficiency · 6: New and emerging treatments for α(1)-antitrypsin deficiency
Alpha-1-antitrypsin (AAT) deficiency is a genetic condition that increases the risk of developing lung and liver disease, as well as other associated conditions. Most treatment of affected individuals is not specifically directed at AAT deficiency but focuses on the resultant disease state. The only...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Group
2004
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1746849/ https://ncbi.nlm.nih.gov/pubmed/15454659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thx.2003.006551 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|